Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.3.0.814
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2015
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Three Months Ended
 September 30,		   Nine Months Ended
 September 30,
Franchised clinics:   2015   2014   2015   2014
Clinics open at beginning of period     239       215       242       175  
Opened during the period     13       16       36       57  
Acquired during the period     (2 )     -       (23 )     -  
Closed during the period     (2 )     (1 )     (7 )     (2 )
Clinics in operation at the end of the period     248       230       248       230  
    Three Months Ended
 September 30,		   Nine Months Ended
 September 30,
Company-owned or managed clinics:   2015   2014   2015   2014
Clinics open at beginning of period     23       -       4       -  
Opened during the period     4       -       4       -  
Acquired during the period     2       -       23       -  
Closed during the period     -       -       (2 )     -  
Clinics in operation at the end of the period     29       -       29       -  
                                 
Total clinics in operation at the end of the period     277       230       277       230  
                                 
Clinic licenses sold but not yet developed     180       248       180       248  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended
September 30,
  
Nine Months Ended
September 30,
    2015   2014   2015   2014
                 
Net loss   $ (1,656,722 )   $ (202,373 )   $ (5,416,317 )   $ (464,019 )
                                 
Weighted average common shares outstanding - basic     9,844,964       4,828,122       9,777,119       4,819,861  
Effect of dilutive securities:                                
Stock options     -       -       -       -  
Weighted average common shares outstanding - diluted     9,844,964       4,828,122       9,777,119       4,819,861  
                                 
Basic and diluted loss per share   $ (0.17 )   $ (0.04 )   $ (0.55 )   $ (0.10 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Three Months Ended
September 30,		   Nine Months Ended
September 30,
    2015   2014   2015   2014
Unvested restricted stock     393,339       542,354       393,339       542,354  
Stock options     524,600       266,555       524,600       266,555  
Warrants     90,000       -       90,000       -